TREATMENT OF A PEDIATRIC PATIENT WITH AN H3.3 K27M MUTANT DIPG WITH ONC201, A SELECTIVE DRD2 ANTAGONIST

被引：0
|
作者：
Suarez, Fernando [1 ]
Stafford, James M. [1 ]
Tarapore, Rohinton [2 ]
Oster, Wolfgang [2 ]
Allen, Joshua E. [2 ]
Chi, Andrew S. [1 ]
Gardner, Sharon [1 ]
机构：
[1] NYU Langone Hlth, New York, NY USA
[2] Oncoceutics, Philadelphia, PA USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DIPG-54
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [41] K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
    Dong-Anh Khuong-Quang
    Buczkowicz, Pawel
    Rakopoulos, Patricia
    Liu, Xiao-Yang
    Fontebasso, Adam M.
    Bouffet, Eric
    Bartels, Ute
    Albrecht, Steffen
    Schwartzentruber, Jeremy
    Letourneau, Louis
    Bourgey, Mathieu
    Bourque, Guillaume
    Montpetit, Alexandre
    Bourret, Genevieve
    Lepage, Pierre
    Fleming, Adam
    Lichter, Peter
    Kool, Marcel
    von Deimling, Andreas
    Sturm, Dominik
    Korshunov, Andrey
    Faury, Damien
    Jones, David T.
    Majewski, Jacek
    Pfister, Stefan M.
    Jabado, Nada
    Hawkins, Cynthia
    ACTA NEUROPATHOLOGICA, 2012, 124 (03) : 439 - 447
  • [42] Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
    Lewis, Nichole A.
    Klein, Rachel Herndon
    Kelly, Cailin
    Yee, Jennifer
    Knoepfler, Paul S.
    EPIGENETICS & CHROMATIN, 2022, 15 (01)
  • [43] Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
    Nichole A. Lewis
    Rachel Herndon Klein
    Cailin Kelly
    Jennifer Yee
    Paul S. Knoepfler
    Epigenetics & Chromatin, 15
  • [44] K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
    Dong-Anh Khuong-Quang
    Pawel Buczkowicz
    Patricia Rakopoulos
    Xiao-Yang Liu
    Adam M. Fontebasso
    Eric Bouffet
    Ute Bartels
    Steffen Albrecht
    Jeremy Schwartzentruber
    Louis Letourneau
    Mathieu Bourgey
    Guillaume Bourque
    Alexandre Montpetit
    Genevieve Bourret
    Pierre Lepage
    Adam Fleming
    Peter Lichter
    Marcel Kool
    Andreas von Deimling
    Dominik Sturm
    Andrey Korshunov
    Damien Faury
    David T. Jones
    Jacek Majewski
    Stefan M. Pfister
    Nada Jabado
    Cynthia Hawkins
    Acta Neuropathologica, 2012, 124 : 439 - 447
  • [45] Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
    Duchatel, Ryan J.
    Mannan, Abdul
    Woldu, Ameha S.
    Hawtrey, Tom
    Hindley, Phoebe A.
    Douglas, Alicia M.
    Jackson, Evangeline R.
    Findlay, Izac J.
    Germon, Zacary P.
    Staudt, Dilana
    Keamey, Padraic S.
    Smith, Nathan D.
    Hindley, Kate E.
    Cain, Jason E.
    Andre, Nicolas
    La Madrid, Andres Morales
    Nixon, Brett
    De Luliis, Geoffry N.
    Nazarian, Javad
    Irish, Kathleen
    Alvaro, Frank
    Eisenstat, David D.
    Beck, Alexander
    Vitanza, Nicholas A.
    Mueller, Sabine
    Morris, Jonathan C.
    Dun, Matthew D.
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
  • [46] CLINICAL AND RADIOGRAPHIC RESPONSE TO ONC201 IN A PEDIATRIC PATIENT WITH A THALAMIC H3K27M AND BRAFV600E MUTANT DIFFUSE MIDLINE HIGH GRADE GLIOMA
    Duke, Elizabeth
    Murnick, Jonathan
    Tarapore, Rohinton
    Allen, Joshua
    Kilburn, Lindsay
    NEURO-ONCOLOGY, 2020, 22 : 303 - 303
  • [47] Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma.
    Arrillaga, Isabel
    Kurz, Sylvia
    Sumrall, Ashley
    Butowski, Nicholas A.
    Harrison, Rebecca A.
    De Groot, John Frederick
    Shonka, Nicole A.
    Lieberman, Frank S.
    Odia, Yazmin
    Tarapore, Rohinton
    Merdinger, Krystal
    Allen, Joshua E.
    Oster, Wolfgang
    Mehta, Minesh P.
    Cloughesy, Timothy Francis
    Chi, Andrew S.
    Lassman, Andrew B.
    Batchelor, Tracy
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [48] INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS
    Chi, Andrew
    Arrillaga-Romany, Isabel
    Gardner, Sharon
    Wen, Patrick
    Batchelor, Tracy
    Hall, Matthew
    Odia, Yazmin
    Khatua, Soumen
    Zaky, Wafik
    McGovern, Susan
    Harrison, Rebecca
    de Groot, John
    Sumrall, Ashley
    Shonka, Nicole
    Khatib, Zaid
    Karajannis, Matthias
    Mueller, Sabine
    Tarapore, Rohinton
    Merdinger, Krystal
    Schalop, Lee
    Allen, Joshua
    Oster, Wolfgang
    Mehta, Minesh P.
    NEURO-ONCOLOGY, 2018, 20 : 19 - 19
  • [49] SINGLE AGENT ACTIVITY OF ONC201 IN NON-MIDLINE H3 K27M-MUTANT DIFFUSE GLIOMAS
    Odia, Yazmin
    Sumrall, Ashley
    Cloughesy, Timothy
    Nghiemphu, Phioanh
    Hall, Matthew
    Daghistani, Doured
    Mehta, Minesh
    Lassman, Andrew
    Arrillaga-Romany, Isabel
    Gardner, Sharon
    Tarapore, Rohinton
    Lu, Guangrong
    Allen, Joshua
    Wen, Patrick
    NEURO-ONCOLOGY, 2021, 23 : 65 - 65
  • [50] SINGLE AGENT ONC201 IN PREVIOUSLY-TREATED, PROGRESSIVE ADULT H3 K27M-MUTANT GLIOMA
    Arrillaga-Romany, Isabel
    Kurz, Sylvia
    Sumrall, Ashley
    Butowski, Nicholas
    Harrison, Rebecca
    DeGroot, John
    Chi, Andrew
    Sulman, Erik
    Shonka, Nicole
    Umemura, Yoshie
    Odia, Yazmin
    Mehta, Minesh
    Iwamoto, Fabio
    Nghiemphu, P. Leia
    Cloughesy, Timothy
    Tarapore, Rohinton
    Merdinger, Krystal
    Oster, Wolfgang
    Allen, Joshua
    Batchelor, Tracy
    Lassman, Andrew
    Wen, Patrick
    NEURO-ONCOLOGY, 2019, 21 : 20 - 21
12345